- Research Article
- 10.1093/oxfmat/itag003
Next-generation atopic dermatitis treatments based on nanotechnology as an effective and low-side-effect solution
- Jan 01, 2026
- Oxford Open Materials Science
- Kamran Ebrahimian + 4 more +4
Abstract Atopic dermatitis (AD) is a chronic inflammatory skin disorder that is characterized by epidermal immune dysregulation, barrier dysfunction, and persistent inflammation. There is no cure for AD yet. Topical treatments often struggle with poor skin absorption, necessitating frequent applications and higher medication doses, which can lead to systemic side effects. In this study, we explore the use of nanotechnology-based topical delivery systems to enhance the therapeutic management of AD. Nanoparticles encapsulating anti-inflammatory drugs enable targeted delivery to the epidermis and upper dermis, where inflammatory processes are most active. This localized release at the site of immune cell infiltration leads to higher local drug concentrations, prolonged skin retention, and reduced systemic exposure. This approach offers several clinical benefits, including a faster therapeutic response, reduced dosing frequency, and improved overall efficacy. Drug delivery represents a promising strategy for optimizing topical AD treatment while minimizing adverse effects.
Read more